Mirbeg-S 25 Tablet ER
Mirbeg-S 25 Tablet ER
Mirabegron (25mg) + Solifenacin (5mg)
Mirabet S 25mg/5mg Tablet ER
Macleods Pharmaceuticals Pvt Ltd
Solifenacin 5mg
Pack Size
1 units
Price
Save ₹47
that's 13% off!
About This Medicine
Product description & overview
Mirbeg-S 25 Tablet ER: Dual-Action Treatment for OAB
Mirbeg-S 25 Tablet ER is a once-daily extended-release formulation containing Mirabegron (25mg) combined with Solifenacin (5mg). This innovative dual-action treatment effectively manages overactive bladder (OAB), specifically by addressing both storage and voiding symptoms.
Mirabegron stimulates β3-adrenergic receptors in the bladder, reducing detrusor muscle contractions. It also relaxes bladder outlet resistance for improved urine flow. Solifenacin is a muscarinic acetylcholine receptor antagonist that relaxes smooth muscles in the bladder neck and urethra, relieving urinary urgency and frequency.
Mirbeg-S 25 Tablet ER provides a stable therapeutic concentration of both medications over time, reducing the need for multiple doses and potentially improving patient compliance. This convenient and effective treatment is ideal for individuals with moderate to severe OAB symptoms, contributing to improved quality of life.
Note: Always consult a healthcare professional before taking any medication. This description is not intended as medical advice.
Active composition
Solifenacin 5 mg
+1 more active ingredient
About Solifenacin
Solifenacin is an antimuscarinic agent used to treat overactive bladder symptoms. It works by relaxing bladder muscles and reducing urgency. Solifenacin's clinical significance lies in its ability to improve bladder control. In summary, Solifenacin is beneficial for managing urinary incontinence.
How It Works
Solifenacin antagonizes muscarinic receptors in the bladder, reducing detrusor muscle contractions and increasing bladder capacity.
All Active Ingredients
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Information regarding the use of Mirbeg-S 25 Tablet ER during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Mirbeg-S 25 Tablet ER during breastfeeding is not available. Please consult your doctor.
Medical Advice
Driving
There is limited information available on the use of Mirbeg-S 25 Tablet ER in patients with kidney disease. Please consult your doctor.
Exercise Caution
Breastfeeding
It is not known whether Mirbeg-S 25 Tablet ER alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Kidney
There is limited information available on the use of Mirbeg-S 25 Tablet ER in patients with liver disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Mirbeg-S 25 Tablet ER